Nanotechnology synergized immunoengineering for cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanotechnology synergized immunoengineering for cancer

Published:2021-06 Issue: Volume:163 Page:72-101
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Chauhan Deepak S.,Dhasmana Anupam,Laskar Partha,Prasad Rajendra,Jain Nishant K.,Srivastava Rohit,Jaggi Meena,Chauhan Subhash C.,Yallapu Murali M.

Funder

NIH

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference315 articles.

1. Conventional cancer therapy: promise broken or promise delayed?;Tannock;Lancet,1998

2. Interval between Symptom Onset and Diagnosis of Pediatric Solid Tumors;Pollock;J. Pediatr.-Us,1991

3. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma;Sieniawski;J. Clin. Oncol.,2007

4. Cancer immunotherapy: Pros, cons and beyond;Tan;Biomed. Pharmacother.,2020

5. Natural innate and adaptive immunity to cancer;Vesely;Annu. Rev. Immunol.,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bibliometric analysis of drug resistance in immunotherapy for breast cancer: trends, themes, and research focus;Frontiers in Immunology;2024-08-12

2. A comprehensive review of phytochemicals of Withania somnifera (L.) Dunal (Solanaceae) as antiviral therapeutics;Discover Applied Sciences;2024-04-03

3. Emergence and impact of theranostic‐nanoformulation of triple therapeutics for combination cancer therapy;Smart Medicine;2024-01-30

4. pH-Responsive manganese sulfide nanotheranostics amplifying cGAS-STING activation for MRI-guided immunotherapy;New Journal of Chemistry;2024

5. Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy;Journal of Controlled Release;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3